Podcasts about pharmaceuticals

"Older adults have this special clarity about who they are and what they want, which is incredibly inspiring," says Dr. Julia Hiner, explaining, in part, why she loves her work as a geriatrician in Houston, Texas. She also enjoys the challenge of the medical complexity these patients present and the opportunity it creates to see the patient as a whole person. In fact, as you'll hear in this upbeat conversation with Raise the Line host Lindsey Smith, there's almost nothing about geriatrics that Dr. Hiner does not enjoy, which explains her passion for teaching the subject at McGovern Medical School at the University of Texas Health Science Center in Houston and trying to convince more students to pursue it as their specialty.  The need is great, given that there are only 8,000 geriatricians in the US despite a rapidly growing senior population. Tune in to learn why Dr. Hiner thinks clinicians avoid the field and the steps that can be taken to improve the situation, including requiring courses in geriatrics. You'll also learn about the importance of capacity assessments, the troubling, and under-reported, problem of elder mistreatment, ageism among health professionals and much more in this super informative episode. Mentioned in this episode:University of Texas Health Science Center at Houston McGovern Medical School  If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Risa Arin doesn't just talk about health literacy. She built the damn platform. As founder and CEO of XpertPatient.com (yes, expert with no E), Risa's taking a wrecking ball to how cancer education is delivered. A Cornell alum, cancer caregiver, and ex-agency insider who once sold Doritos to teens, she now applies that same marketing muscle to helping patients actually understand the garbage fire that is our healthcare system. We talk about why she left the “complacent social safety” of agency life, how her mom unknowingly used her own site during treatment, what it's like to pitch cancer education after someone pitches warm cookies, and why healthcare should come with a map, a translator, and a refund policy. Risa brings data, chutzpah, and Murphy Brown energy to the conversation—and you'll leave smarter, angrier, and maybe even a little more hopeful.RELATED LINKS• XpertPatient.com• Risa Arin on LinkedIn• XpertPatient & Antidote Partnership• XpertPatient Featured on KTLA• 2024 Health Award BioFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

In this episode of EisnerAmper's Private Equity Dealbook, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Kapila Ratnam, Partner with the healthcare fund at NewSpring Capital, a Pennsylvania-based lower middle market private equity firm. She discusses some of the transactions NewSpring has completed in the pharmaceutical space, including Kincell Bio and Aerosafe Global. She walks us through the processes, along with both the opportunities and challenges faced when it came to those transactions. She also discusses the due diligence process on those deals and more.

Dr. Jamie Wells is back—and this time, she brought a book. We cover everything from biomedical design screwups to the glorified billing software known as the EHR. Jamie's new book, A Clinical Lens on Pediatric Engineering, is a masterclass in what happens when you stop treating kids like small, drunk adults and start designing medicine around actual human factors. We talk about AI in pediatric radiology, why drug repurposing might save lives faster than biotech IPOs, and the absurdity of thinking one-size-fits-all in healthcare still works.Jamie's a former physician, a health policy disruptor, a bioethicist, an MIT director, and a recovering adjunct professor. She's also a unicorn. We dig into the wonk, throw shade at bad design, and channel our inner Lisa Simpsons. This one's for anyone who ever wondered why kids' hospitals feel like hell and why “make it taste like bubblegum” might be the most important clinical innovation of all time. You'll laugh, you'll learn, and you might get angry enough to fix something.RELATED LINKSJamie Wells on LinkedInBook: A Clinical Lens on Pediatric Engineering (Amazon)Book on SpringerDrexel BioMed ProfileGlobal Blockchain Business CouncilJamie's HuffPost ArticlesFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After months of litigation in a federal district court, a key decision recently came out in the legal fight over 340B drug rebates. 340B Health Vice President of Legal and Policy Amanda Nagrotsky updates us on the development.Court deals a blow to drugmakersD.C. district court judge Dabney Friedrich ruled on May 15 that manufacturers cannot unilaterally implement rebate models for 340B, agreeing with the Health Resources & Services Administration (HRSA) that the agency effectively has preapproval authority over rebates. In her decision, the judge cited early results from a 340B Health survey finding that shifting 340B to a rebate model would divert significant hospital resources from patient care. Drugmakers have already appealed the ruling.Some bright spots for drugmakers in this decisionAlthough the decision largely went against pharmaceutical companies, the judge ruled that the 340B statute does not categorically prohibit rebates, leaving the door open for government approvals of rebates. The judge also agreed with drugmakers' assertions that HRSA should consider how rebate models could improve 340B compliance and how requiring the sharing of data through rebates could aid in drug company audits of covered entities.Will HRSA stop all rebates from proceeding?Despite this decision, the legal fight over rebates isn't over yet. The judge found that, for three of the manufacturers in these cases, HRSA has yet to issue final decisions with respect to their proposed rebate models. In the case of Sanofi, the judge found that HRSA failed to adequately explain the legal basis for rejecting the drugmaker's rebate model, and she directed the agency to reconsider its decision and explain whether and how it would violate the 340B statute. HRSA sent rebate guidance to the White House for approval earlier this month, though as of recording this episode it was not known what that guidance would say.ResourcesRead Our Analysis of the First Federal Court Decision on Rebates340B Health Continues Court Fight Against Rebates

In this episode of the Boost Your Biology podcast, Lucas Aoun interviews Camilla Thompson, an expert in health optimization and biohacking. Camilla shares her personal journey with mold toxicity, detailing her struggles with unexplained health issues and the pivotal moments that led her to biohacking as a means of reclaiming her health. The conversation explores the stealth symptoms of mold toxicity, the importance of proper mold inspection and removal, and effective detoxification strategies. Camilla emphasizes the foundational aspects of biohacking, including diet, hydration, and the benefits of intermittent fasting. The episode concludes with practical tips for listeners looking to improve their health and wellness. In this conversation, Lucas Aoun and Camilla discuss various aspects of biohacking, focusing on food responses, sleep optimization, the role of magnesium, and the importance of nutrition in health. They explore the limitations of the current medical system, the impact of pharmaceuticals, and advancements in preventative health technology. The discussion emphasizes the need for education and proactive health measures, as well as the growing interest in biohacking in Australia post-pandemicRelevant links:Camilla's IG: https://www.instagram.com/thewellnesscoach/?hl=en Check Out My Website For Coaching, Recommended Products and Much More:https://www.boostyourbiology.com/ Disclaimer:The information provided in this podcast episode is for entertainment purposes and is NOT MEDICAL ADVICE. If you have any questions about your health, contact a medical professional. This content is strictly the opinions of Lucas Aoun and is for informational and entertainment purposes only. It is not intended to provide medical advice or to take the place of medical advice or treatment from a personal physician. All viewers of this content are advised to consult with their doctors or qualified health professionals regarding specific health questions. Neither Lucas Aoun nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this content. All consumers of this content especially taking prescription or over-the-counter medications should consult their physician before beginning any nutritional, supplement or lifestyle program.Chapters00:00 Introduction to Health Optimization01:03 Camilla's Journey with Mold Toxicity03:54 Identifying Mold Symptoms06:10 Mold Inspection and Removal08:05 Detoxification Strategies11:12 Biohacking Basics and Foundations12:51 Dietary Considerations for Health14:51 Hydration and Water Quality18:00 Daily Nutrition Essentials20:57 Intermittent Fasting and Mental Clarity23:04 Overcoming Challenges in Biohacking25:20 Exploring Food Responses and Biohacking26:40 The Importance of Sleep Optimization28:43 Understanding Magnesium and Its Effects29:39 Innovations in Sleep Technology31:38 Nutrition and Its Role in Health34:03 Rethinking the Medical System36:59 The Role of Pharmaceuticals in Health40:00 Advancements in Preventative Health Technology41:57 The Future of Biohacking in Australia Hosted on Acast. See acast.com/privacy for more information.

"It was pretty apparent to me that something was going on with him," says Kristi Levine, describing the realization that, based on her experience as a Montessori teacher, her infant son, Trey, was missing developmental milestones. Unfortunately, Kristi's hunch turned out to be correct and Trey was later diagnosed with a rare genetic mutation called CACNA1A which is impacting his motor skills, balance, coordination and speech. Kristi and her husband, Eric, join host Michael Carrese on this installment in our Year of the Zebraseries to help us understand the disorder and its implications for Trey and their family, which includes Trey's older sister Stella.  “There's a lot of guilt involved in being a parent of a child who has a disability because you never feel like you're doing enough,” shares Eric, even though they both work full time and have becoming experts at juggling work, caregiving, advocating, and volunteering with the CACNA1A Foundation. In this candid interview, Eric and Kristi discuss the challenges of parenting a child with complex medical needs, the importance of community support, the ongoing search for treatment options, and share some advice for clinicians caring for patients and families living with rare disorders. “We just want medical professionals to respect and understand what we're dealing with on a day-to-day basis and to see our kids holistically, and not just try to fix the problem medically. Understand that for us, the biggest thing that we want for our kids is just their quality of life.”Mentioned in this episode:CACNA1A Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

What if the water in your home is doing more harm than good?In this episode, Neil sits down with Nelson, a U.S. manufacturer and founder of Sentry H2O, to unpack the dirty truth about most filtration systems and what clean water actually looks like in the 21st century.Nelson shares how his decades in product manufacturing led him to build a water filtration company that's not only beating cancer in his own life, but also helping animals live longer, supporting missionaries in Africa, and even getting attention from U.S. political leaders. In This Episode, We Cover:✅ Why Chinese suppliers are sneaking around tariffs and how to avoid their tactics✅ How American-made products are regaining global leverage✅ The toxic truth about “clean” water and what actually gets filtered✅ How Sentry H2O removes fluoride, heavy metals, pharmaceuticals, and nanoplastics✅ Why dogs, horses, and even fish live longer on this water✅ The founder's personal story of using oxygenated water to fight cancer✅ How you can test your water and get a system built specifically for your homeChapters:[00:01:02] Nelson's Background: 25+ Years in Manufacturing[00:02:20] How China Repackages Products to Dodge Tariffs[00:04:00] Why U.S. Manufacturing is Gaining Ground[00:08:03] What Sentry H2O Filters Out (Fluoride, VOCs, Pharmaceuticals, More)[00:14:02] Whole-Home System: From Dishwasher to Shower[00:16:22] Portable Filters Designed for Astronauts and Missionaries[00:18:00] How Nelson Used His Own Water System to Beat a Health Scare[00:23:01] Pets Prefer It: Dogs, Horses, and Even Fish[00:25:35] Use Code “NEIL” at SentryH2O.com for 10 Percent Off[00:27:44] Hydration, Alkalinity, and the Power of Clean Water 

Send us a textOn this week's WTR Small-Cap Spotlight, we speak with Apimeds CEO Erik Emerson about the newly NYSE listed company and the development of Apitox, a purified honeybee venom, for knee osteoarthritis and multiple sclerosis. We discuss the therapeutic properties of bee venom and the clinical/regulatory plans to bring Apitox to the US market. Listen to learn more about Apimeds and its novel approach to treat inflammatory pain.

Whether you've been served an advert for it, or just heard about it in the media, it's likely that 'Ozempic' isn't a totally unfamiliar word. Now often associated with weight-loss, Ozempic is actually the brand name for a drug used to treat diabetes. So what exactly is it, how does it work, and is it safe? We chat to diabetes and endocrinology (hormone) expert Dr Annie de Bray to find out.  

Erica Campbell walked away from corporate life, took a hard left from the British Embassy, and found her calling writing checks for families nobody else sees. As Executive Director of Pinky Swear Foundation, she doesn't waste time on fluff. Her team pays rent, fills gas tanks, and gives sick kids' parents the one thing they don't have—time. Then, breast cancer hit her. She became the patient. Wrote a book about it. Didn't sugarcoat a damn thing. We talk about parking fees, grief, nonprofit burnout, and how the hell you decide which families get help and which don't. Also: AOL handles, John Hughes, and letters from strangers that make you cry. Erica is part Punky Brewster, part Rosie the Robot, and part Lisa Simpson—with just enough GenX Long Island sarcasm to make it all land. This one sticks.RELATED LINKSPinky Swear FoundationThe Mastectomy I Always Wanted (Book)Erica on LinkedInThink & Link: Erica Campbell“Like the Tale of a Starfish” - Blog Post“Cancer Diagnosis, Messy Life, Financial Support” - Blog PostFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Rob Lott interviews Keith Drake of Greylock McKinnon Associates about his recent paper that explores trends in authorized generic drug launches and the effects observed on competition in pharmaceutical markets in the US. Order the June 2025 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter.

Peter Ordentlich, Chief Scientific Officer and Founder at Syndax Pharmaceuticals, a clinical oncology company, is focused on developing precision medicine approaches to treat cancer and chronic graft-versus-host disease. The menin protein plays a critical role in driving certain types of blood cancers, and the Synex therapy is a menin inhibitor that can disrupt this cancer-driving pathway. The platform is also developing an antibody addressing the unmet needs in cGVHD to reduce the disease-driving macrophages. Peter explains, "Syndax is a clinical oncology company, which means we're focused primarily on cancer, and we're primarily doing clinical development. We started the company really looking at resistance pathways to developing cancer, and we've been focused on two main areas. One in the indication space of leukemia, which are certain types of blood cancers, and that's with a program we have around the small molecule drug called revumenib. We are also focused in another area of diseases called chronic graft-versus-host disease. These are diseases that happen post-stem cell transplant, and there we're developing an antibody called axatilimab. And so those two programs are really what we've been focusing on for the last five or six years and have led to each of those drugs." "So menin is a very interesting protein, and basically what this is, it's called a scaffold protein. And you can imagine a scaffold, just something you build things upon. And so menin interacts with DNA through a variety of other factors, and you build on top of this a complex of other proteins that can turn genes on and off. And in the case of certain types of leukemias, the mutation that creates certain other cancer-causing proteins binds to menin. That's what drives certain genes that drive leukemia to always be turned on. And so what we've tried to do and others have tried to do is disrupt that interaction and essentially cause the scaffold to fall apart. And when that falls apart, you can no longer keep those genes on that drive leukemia, and instead, you have genes that essentially cause the cell to stop growing."  #SyndaxPharma #AcuteLeukemia #cGHVD #Oncology #PrecisionMedicine #Menin #MeninInhibitors syndax.com Listen to the podcast here

Peter Ordentlich, Chief Scientific Officer and Founder at Syndax Pharmaceuticals, a clinical oncology company, is focused on developing precision medicine approaches to treat cancer and chronic graft-versus-host disease. The menin protein plays a critical role in driving certain types of blood cancers, and the Synex therapy is a menin inhibitor that can disrupt this cancer-driving pathway. The platform is also developing an antibody addressing the unmet needs in cGVHD to reduce the disease-driving macrophages. Peter explains, "Syndax is a clinical oncology company, which means we're focused primarily on cancer, and we're primarily doing clinical development. We started the company really looking at resistance pathways to developing cancer, and we've been focused on two main areas. One in the indication space of leukemia, which are certain types of blood cancers, and that's with a program we have around the small molecule drug called revumenib. We are also focused in another area of diseases called chronic graft-versus-host disease. These are diseases that happen post-stem cell transplant, and there we're developing an antibody called axatilimab. And so those two programs are really what we've been focusing on for the last five or six years and have led to each of those drugs." "So menin is a very interesting protein, and basically what this is, it's called a scaffold protein. And you can imagine a scaffold, just something you build things upon. And so menin interacts with DNA through a variety of other factors, and you build on top of this a complex of other proteins that can turn genes on and off. And in the case of certain types of leukemias, the mutation that creates certain other cancer-causing proteins binds to menin. That's what drives certain genes that drive leukemia to always be turned on. And so what we've tried to do and others have tried to do is disrupt that interaction and essentially cause the scaffold to fall apart. And when that falls apart, you can no longer keep those genes on that drive leukemia, and instead, you have genes that essentially cause the cell to stop growing."  #SyndaxPharma #AcuteLeukemia #cGHVD #Oncology #PrecisionMedicine #Menin #MeninInhibitors syndax.com Download the transcript here

About this episode: Would it be a good idea to have tariffs on pharmaceuticals? In this episode: a conversation about the rationales for tariffs as well as potential downsides—like higher drug prices—and what could really help with supply and pricing issues. Guest: Dr. Mariana Socal studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains—Johns Hopkins Carey Business School Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages—NBC Los Angeles Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Bryan Moskow: MS Organic & Biochemistry UCF/GT, PhD Student at Georgia Tech, Offseason/Prep Protocols & Hormone OptimizationThe Bodybuilding-friendly HRT Clinic - Get professional medical guidance on peptides AND optimizing your health as a man or bodybuilder:[ Pharma Test, IGF1, Tesamorelin, Glutathione, BPC, Semaglutide, Var troche, etc]https://transcendcompany.com/patient-intake-form/?ls=Nyle+NaygaWatch it: https://www.youtube.com/watch?v=6Ihq4tIzyS8&t=5618sRP Hypertrophy Training App: rpstrength.com/nylePlease share this episode if you liked it. To support the podcast, the best cost-free way is to subscribe and please rate the podcast 5* wherever you find your podcasts. Thanks for watching.To be part of any Q&A, follow trensparentpodcast or nylenayga on instagram and watch for Q&A prompts on the story  https://www.instagram.com/trensparentpodcast/Huge Supplements (Protein, Pre, Defend Cycle Support, Utilize GDA, Vital, Astragalus, Citrus Bergamot): https://www.hugesupplements.com/discount/NYLESupport code 'NYLE' 10% off - proceeds go towards upgrading content productionYoungLA Clothes: https://www.youngla.com/discount/nyleCode ‘NYLE' to support the podcastLet's chat about the Podcast:Instagram: https://www.instagram.com/trensparentpodcast/TikTok: https://www.tiktok.com/@transparentpodcastPersonalized Bodybuilding Program:  https://www.nylenaygafitness.com00:00 - Intro01:47 - Steroids and PEDs in Bodybuilding  02:59 - Podcast Setup and Audio Talk  03:41 - Science Without an Agenda  04:22 - GLP-1 and GLP-300008:19 - Insulin, Diets, and Brain Health  10:26 - Berberine and Supplement Bioavailability  13:04 - Beta-Alanine and Sodium Bicarbonate  14:59 - Citing Studies and Research Quality  17:32 - Natural Alternatives to Pharmaceuticals  19:34 - Esters and Compound Solubility  21:29 - Brian's Bodybuilding Journey  24:56 - Steroid Protocols and Half-Lives  30:34 - PCT and Fertility Strategies  38:44 - HCG and Male Contraception  41:53 - SARMs and Their Risks  46:08 - GHB as a Supplement  47:40 - GHB Risks and College Stories  50:32 - Prescription GHB and GABA Dangers  51:48 - Long-Term Effects of Sleep Meds 

Kinsella on Liberty Podcast: Episode 467. I was asked one Juani (@witheredsummer), an Argentinian Voluntarist, on Twitter and then later via email, to review his draft article "Ideas Are Free: A Case Against Intellectual Property" (text below) (I note that perhaps ironically, this title is almost identical to one of my own previous publications/speeches, Ideas are Free: The Case Against Intellectual Property: or, How Libertarians Went Wrong). I told him it was too long for me to fisk, got Grok to analyze it (see below), and told him to read up on some of my work and review the analysis, so that we could have a more productive conversation about it, and which I could also at least record for my podcast. This is our discussion. In the end, he didn't really have many questions and I think he just wanted to vent about how bad IP is and express frustration at out outrageous and harmful it is. And suggest some ways to get through to people and propose reforms. Things I already knew and have been writing about for 30 years. He basically identifies many problems with and absurdities with IP law ... which he's right about and which I've mentioned ... and comes up with some proposals for IP reform that would reduce its harm. Again, which he's right about and which I and others have also proposed, but also which are unlikely to be adopted by those infested with the IP mind-virus. Not really sure what the point of this was, but here it is FWIW. https://youtu.be/AS-8mFZGfnI GROK SHOWNOTES: [0:00-15:00] In this episode of the Stephan Kinsella podcast (KOL467), host Stephan Kinsella engages with Juani from Argentina to discuss intellectual property (IP) and its implications, particularly in the context of artificial intelligence (AI). Juani, a programmer and self-described libertarian, shares his consequentialist critique of IP, influenced by Kinsella's work and his own essay, "Ideas for Free: A Case Against Intellectual Property." The conversation begins with Juani outlining his concerns about IP's practical harms, such as its impact on innovation and culture, and transitions into a discussion about AI. They explore how AI's reliance on vast datasets, often containing copyrighted material, raises legal questions about copying, authorship, and derivative works. Kinsella highlights the tension between copyright law and AI development, noting that current laws could stifle AI's potential by limiting data access or imposing costly licensing requirements. [15:01-1:37:33] The discussion deepens into specific examples of IP's negative effects, including cultural erasure through Disney's sanitized retellings of historical figures like Pocahontas and Mulan, and the economic burdens of pharmaceutical patents, which restrict access to life-saving drugs in poorer nations. Juani argues that IP acts as a form of censorship and reinforces wealth disparities, citing cases like patent trolling and the high cost of educational materials in developing countries. Kinsella agrees, emphasizing that IP distorts markets and innovation, and suggests that copyright's harm to AI development may rival its threat to internet freedom. Toward the end, Juani proposes a reform to replace IP exclusivity with a decaying royalty system, which Kinsella views skeptically, arguing that entrenched IP proponents will resist any reduction in rights. The episode concludes with reflections on piracy, the success of platforms like Steam, and the cultural shift toward viewing copying as less harmful, signaling a potential change in public perception of IP.   Youtube Transcript and detailed Grok shownotes below. Related: KOL466 | On IP Reform and Improving IP law FDA and Patent Reform: A Modest Proposal “Absurd Arguments for IP” “The Patent, Copyright, Trademark, and Trade Secret Horror Files” Boldrin & Levine on Covid-19, Vaccines, the Pharmaceutical Industry, and Patents Patents and Pharmaceuticals

Send us a textA critique of SSRIs and pharma's influence on medicine, including SSRI-induced sexual dysfunction, suicidality, and violence. Long Summary: Dr. David Healy critiques modern medicine, focusing on SSRIs and psychiatric medicine, including: how pharmaceutical companies manipulate clinical trial data, ghostwrite studies, and influence medical practice, often ignoring patient experiences; highlighting issues like post-SSRI sexual dysfunction (PSSD), the immediate sensory effects of SSRIs, and their potential to induce suicidal or violent behavior; challenging the reliance on randomized controlled trials (RCTs) over individual patient reports; and more.About the guest: David Healy, MD, PhD, a psychiatrist and pharmacologist, has decades of experience researching the serotonin system and SSRIs, working across Ireland, the UK, Canada, and the US. He is a professor at McMaster University and a vocal critic of pharmaceutical industry practices.Discussion Points:SSRIs cause near-immediate sensory effects, like genital numbing, in most people.Post-SSRI sexual dysfunction (PSSD) can persist for years or decades after stopping the drug, affecting many long-term users.Healy argues RCTs prioritize averages over individual experiences, often missing serious side effects like suicidality.Pharmaceutical companies ghostwrite studies and manipulate data, with journals like the New England Journal of Medicine publishing misleading articles.Serotonin theory of depression lacks evidence.Industry tactics include dismissing patient reports as anecdotes and using high doses in trials to mask weak efficacy.SSRIs can increase suicide risk, not just during initiation but also when adjusting doses or withdrawing, as seen in cases like the Aurora movie theater shooting.Regulatory bodies like the FDA often fail to investigate adverse effects due to bureaucratic processes and lack of follow-up.Healy emphasizes doctors' failure to prioritize patient observations, driven by industry-influenced standards of care.Related episode:M&M 88: Depression, Serotonin, SSRIs, Psychiatry & Social Media | Joanna Moncrieff*Not medical advice.Support the showAll episodes, show notes, transcripts, and more at the M&M Substack Affiliates: KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off Readwise: Organize and share what you read. 60 days FREE through link SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. MASA Chips—delicious tortilla chips made from organic corn & grass-fed beef tallow. No seed oils or artificial ingredients. Code MIND for 20% off For all the ways you can support my efforts

Julio Martinez-Clark teamed up with his cardiologist brother and other doctors to help speed up the clinical trials part of the process. Julio's team at bioaccess® is moving medicine forward quicker by helping startups and researchers get the data from clinical trials in other countries. Advancements can now come to market quicker while also helping suffering people in countries that do not have the means to afford the proper medical care. This saves time, money, and people.Julio Martinez-Clark is the co-founder and CEO of bioaccess®. Julio believes Latin America is an untapped destination for Medtech clinical research. Since 2010, Julio has supported +100 Medtech in operationalizing successful clinical trials in several countries in Latin America. Julio was the chairman of the board of the Association for the Advancement of Clinical Research in Colombia (AVANZAR). Julio writes a column at Med Device Online, where his articles have been "Featured Editorials" on several occasions. Julio hosts the LATAM Medtech Leaders podcast, interviewing Medtech leaders who have succeeded in Latin America.Julio has a wealth of experience in various fields, including serving as an advisor to the CEO of Amavita Heart and Vascular Health™, the most extensive cardiovascular practice in South Florida, an advisor to government agencies in Colombia looking to position the country as a clinical trial destination, and a mentor to startups at Macondo Labs, a top incubator in Colombia.Learn more at www.bioaccessla.com and connect with Julio on Linkedin @juliomartinezclark Visit ConfidenceThroughHealth.com to find discounts to some of our favorite products.Follow me via All In Health and Wellness on Facebook or Instagram.Find my books on Amazon: No More Sugar Coating: Finding Your Happiness in a Crowded World and Confidence Through Health: Live the Healthy Lifestyle God DesignedProduction credit: Social Media Cowboys

Allyson with a Y. Ocean with two Ls. And zero chill when it comes to changing the face of cancer care. Dr. Allyson Ocean has been quietly—loudly—at the center of every major cancer breakthrough, nonprofit board, and science-backed gut punch you didn't know you needed to hear. In this episode, she joins me in-studio for a conversation two decades in the making. We talk twin life, genetics, mitochondrial disease, and why she skipped the Doublemint Twins commercial but still ended up as one of the most recognizable forces in oncology. We cover her nonprofit hits, from Michael's Mission to Let's Win Pancreatic Cancer to launching the American Jewish Medical Association—yes, that's a thing now. We get personal about compassion in medicine, burnout, bad food science, and microplastics in your blood. She also drops the kind of wisdom only someone with her résumé and sarcasm can. It's raw. It's real. It's the kind of conversation we should've had 20 years ago—but better late than never.RELATED LINKS:– Dr. Allyson Ocean on LinkedIn– Let's Win Pancreatic Cancer– NovoCure Leadership Page– Michael's Mission– American Jewish Medical Association– The POLG Foundation– Cancer Buddy App (Bone Marrow and Cancer Foundation)– Dr. Ocean at OncLiveFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

(June 03,2025)China's grip on the global pharmaceuticals industry is exposed by the Trump administration's tariff threat. Mosquitos could be driven to extinction with gene editing, but is that a good thing? 

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Regeneron's shares have dropped due to the failure of their dupixent follow-up drug, while Sanofi has acquired Blueprint for $9.5 billion to expand their rare disease portfolio. Bristol Myers Squibb is collaborating with Biontech on a bispecific antibody for solid tumors, and Amgen's imdelltra has shown a 40% increase in survival for small cell lung cancer at ASCO. Moderna has received FDA approval for their next-gen COVID-19 vaccine, and AstraZeneca is partnering with AI companies to stop cancer at all stages. Keros has cut 45% of its workforce along with a pulmonary hypertension drug, and Jazz has presented new cancer data at ASCO. FDA actions are pending for companies like Merck, Gilead, and Regeneron/Sanofi.The implications of the overturning of the FDA's lab-developed tests rule in a post-Chevron legal landscape are discussed, where power has shifted from federal agencies to the courts. Upcoming FDA decisions, including Gilead's HIV prophylaxis lenacapavir, are highlighted, along with new FDA guidelines on nitrosamine testing for the pharmaceutical industry. Jazz Pharmaceuticals is in the "goldilocks zone" with new cancer data at ASCO25, showcasing results from acquisitions made over the past five years. Zeiss introduces an AI-powered spatial biology solution for research labs. Other news includes updates from ASCO25, cell and gene therapy developments, and upcoming events in the biopharma industry.

In the fast-paced world of entrepreneurship, self-care often takes a backseat. This episode of Business Chop brings you Dr. Tamar Lawful, a distinguished pharmacist and CEO of Lyfe Balance Inc., who shares her journey from traditional pharmacy to advocating for holistic health and self-care.From Prescription Pads to Personalized Wellness Dr. Lawful's 21-year career in pharmacy took an unexpected turn when she realized that simply dispensing medications wasn't truly helping patients achieve lasting health. Her innovative approach now combines:Nutritional genomicsLifestyle modificationsPersonalized health coachingThe DNA Strategy: A Path to Sustainable Health Dr. Lawful introduces her three-phase DNA strategy for achieving a balanced, healthier lifestyle:Detox your mind from preconceived notions about healthNourish your body with tailored nutrition and exerciseAlign your actions with your health goalsNutrigenomics: Unlocking Your Body's Unique CodeLearn how Dr. Lawful uses genetic testing to create personalized nutrition and lifestyle plans. This cutting-edge approach helps clients:Understand their genetic predispositionsAddress root causes of health issuesAchieve lasting results beyond traditional methodsDr. Lawful emphasizes the importance of daily self-care practices, tailored to each individual's needs. Discover how small, consistent actions can lead to significant improvements in overall well-being and productivity.A Special Gift to Support Your Wellness Journey  As a Business Chop listener, you'll receive a complimentary $500 Nutrigenomic Test when you join the LYFE Balance 90-Day Health Coaching Program. Let's discover what your body needs—book your FREE consultaSend us a messageBuzzsprout - Let's get your podcast launched!Start for FREEDesignrr for eBooks, BlogsCreate eBooks, Blogs, Lead Magnets and more! Riverside.fm Your Own Virtual StudioProfessional Virtual StudioAltogether Domains, Hosting and MoreBringing your business online - domain names, web design, branded email, security, hosting and more.Digital Business CardsLet's speed up your follow up. Get a digital business card.Small Business Legal ServicesYour Small Business Legal Plan can help with any business legal matter.Mens and Womens HatsSince 1972, American Hat Makers has been dedicated to the art of fine hat making.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showWant to be a guest on Business Chop? Send Audrey Wiggins a message on PodMatch, here: podmatch.com/hostdetailpreview/audreywiggins Please Rate & ReviewTo work with Audrey schedule a breakthrough/discovery session.

تواصل معانا وشاركنا افكاركما الذي يدفع شخصًا ناجحًا للتخلي عن مهنة مرموقة في المصرفية الاستثمارية والمخاطرة بكل شيء في صناعة لا يملك فيها أي خبرة أو حتى شغف؟في هذه المحادثة الصريحة والعميقة، يكشف صلاح مؤنس، الرئيس التنفيذي والمؤسس المشارك لشركة كليو فارماسوتيكل، عن الرحلة غير التقليدية التي قادته من عالم التمويل إلى عالم مستحضرات التجميل والعناية الشخصية. بدايةً من كرسيين في مساحة عمل مشتركة إلى بناء واحدة من أكبر منصات التجارة الإلكترونية في مصر تشحن أكثر من 7000 وحدة يوميًا، قصة صلاح تتحدى المفاهيم التقليدية حول الشغف كشرط مسبق للنجاح.نستكشف معًا اللحظات الحاسمة في رحلته: من جذور خبرته في المصرفية الاستثمارية، إلى كيفية استخدامه لمهاراته في الإدارة المالية لبناء شركة تنمو ذاتيًا دون الحاجة لمستثمرين خارجيين، وكيف حوّلت الجائحة العالمية مسار الشركة بشكل جذري. يشارك صلاح بصراحة تامة التحديات الشخصية والمهنية التي واجهها، واستراتيجيات البقاء في سوق متقلب، وكيفية اختيار وبناء فريق عمل فعّال.سواء كنت رائد أعمال طموحًا، أو مهنيًا تفكر في تغيير مسارك الوظيفي، أو مهتمًا بفهم ديناميكيات نجاح الشركات الناشئة في أوقات الاضطراب الاقتصادي، ستجد في قصة صلاح مؤنس دروسًا قيمة ورؤى عملية يمكن تطبيقها في رحلتك الخاصة. اشترك الآن واستمع لهذه القصة الملهمة التي تثبت أن أعظم النجاحات قد تأتي من أكثر المنعطفات غير المتوقعة في حياتنا.Support the showرعاة بودكاست بزنس بالعربي:

Sponsored by Invivyd, Inc.Nobody wants to hear about COVID-19 anymore. Especially not cancer patients. But if you've got a suppressed immune system thanks to chemo, radiation, stem cell transplants—or any of the other alphabet soup in your chart—then no, it's not over. It never was. While everyone else is getting sweaty at music festivals, you're still dodging a virus that could knock you flat.In this episode, Matthew Zachary and Matt Toresco say the quiet part out loud: many immunocompromised people may not even know they have options beyond vaccines. Why? Because the system doesn't bother to tell them. So we're doing it instead. We teamed up with Invivyd to help get the word out about tools other than vaccines that can help prevent COVID-19. We break down the why, the what, and the WTF of COVID-19 risk for cancer patients and why every oncologist should be talking about this.No fear-mongering. No sugarcoating. Just two guys with mics who've been through it and want to make sure you don't get blindsided. It's fast, funny, and furious—with actual facts. You've got more power than you think. Time to use it.RELATED LINKSExpand Their OptionsInvivydMatt Toresco on LinkedInOut of Patients podcastFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Much like the popularity of methylene blue, the building popularity of nicotine pouches has produced a sort of health sub-culture within the larger context of a generally unhealthy population. Whereas methylene blue is relatively new to the public, nicotine has been around, and much more popular, for a lot longer. Sure, methylene blue has certain medical benefits, namely as a supplement for those with methemoglobinemia, though too much of the substance can cause the same condition. Though it goes with anything - quantity, quality, long term use, additional additives, and health context matter. The same goes for nicotine pouches. Nicotine, especially the non-smoked kind, can benefit cognition, memory, and concentration to a small degree, though delivery mechanisms and quality matter greatly.  Could it be that these recent health potions are nothing more than a commodifying and monetizing not only of health but of the healthcare revolution?The bottom line is this: Big Tobacco lied, obfuscated and killed for decades. By the 1980s and 1990s, studies, high profile cases, and lawsuits put some final nails in their coffin. It was around this time that these companies began to diversify heavily. Phillip Morris purchased General Foods, Kraft, and Miller Brewing in the 80s, and a little later Nabisco in 2000. R.J. Reynolds had purchased the same company in the 80s. They also had control of Pacific Hawaiian products since the 60s. These acquisitions allowed tobacco companies to apply cigarette marketing tactics, like targeting children and minorities, and to develop "hyper-palatable" foods high in fat, sugar, and sodium, influencing the U.S. food system for decades.Vaping was then introduced in the early 2000s and within a few years Big Tobacco was diversifying again. In 2014 MarkTen e-cigarettes were introduced by Altria (Phillip Morris) and Vuse was introduced by R.J. Reynolds (BAT). Soon after Altria introduced ON!, British American Tobacco (R.J. Reynolds) launched VELO, and Phillip Morris acquired ZYN. When vaping began to develop a bad reputation for some, the industry convinced many that cigarettes were the safer choice, while others kept vaping for the same reason.Although these companies had marketed nicotine gum and patches for decades, the market grew rapidly as people tried to stop smoking in general. But what about the market for non-smokers? Well, that's where ON!, ZYN, and VELO come in. Instead of chewing tobacco, cigarettes, patches or gum, pouches were for all non-smokers and promoted as having health benefits. By the time these pouches were largely under the control of Big Tobacco there began a campaign of promotion on social media, primarily TikTok, for flavored nicotine pouches - as with flavored cigarettes and vapes. Now they have been picked up by conservatives and those leaning in the direction of MAHA. It all makes sense, too, when considering what the HHS and NIH have done so far under RFK Jr. Although certain vaccines are longer advised for healthy kids and pregnant women, the HHS and NIH are investing millions, maybe billions, in “universal influenza and coronavirus vaccines.” With Project Stargate there is further investment in personalized medicine and vaccines, followed up in May, 2025, with three other interesting developments. May 5 saw the White House strip regulations for domestic pharmaceutical manufacturing and May 12 saw the White House authorize that “the Secretary of Health and Human Services (Secretary) shall facilitate direct-to-consumer purchasing programs for pharmaceutical manufacturers that sell their products to American patients at the most-favored-nation price." On May 19 the HHS posted about RFK Jr meeting with technocrats “creating wearable devices, AI tools, and personalized apps that empower Americans to take control of their health.” What all of this really does is allow for the mass collection of personal health data so that even more accurate health models can be created in order to personalized marketing and products that can be sold directly to the public with no middle party, while also empowering insurance companies to take advantage of knowing who can be charged more for private decisions. This isn't revolution, it's commodification and monetization. And at the very least, anyone advocating for methylene blue, itself a “fetotoxic agent,” or nicotine pouches without first examining all the free ways we can be healthier, or without noting that the first is a dye and the second is sold by a famously corrupt and evil industry, is either untrustworthy, ignorant, or a sell out. *The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.-FREE ARCHIVE (w. ads)SUBSCRIPTION ARCHIVEX / TWITTER FACEBOOKYOUTUBEMAIN WEBSITECashApp: $rdgable Paypal email rdgable1991@gmail.comEMAIL: rdgable@yahoo.com / TSTRadio@protonmail.comBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-secret-teachings--5328407/support.

We have a special guest on today's episode whose voice will be familiar to regular listeners. Last year at this time, Dr. Raven Baxter occupied the Raise the Line host chair for a special ten-part series we produced in collaboration with the Cohen Center for Recovery from Complex Chronic Illness (CoRe) at Mount Sinai in New York City, where she serves as the Director of Science Communication. The series explored the latest understandings of post-acute infection syndromes -- such as Chronic Lyme and Long COVID -- with an array of experts from the Center and other researchers and providers. In this episode, we check-in with Dr. Baxter to get an update on the work of the Cohen Center, especially with regard to its mission to educate providers. “We're building programs so that clinicians can earn credit for learning about chronic illnesses that are infection associated, and we've also developed a 200-page provider manual. I really think that we will be able to shift the narrative that currently exists,” Dr. Baxter tells host Michael Carrese. That narrative includes lingering skepticism among providers of some infection-associated illnesses, which Dr. Baxter witnessed herself as a Long COVID patient, an experience that has added meaningful perspective to her work. Dr. Baxter is also working on her own time to advance knowledge and combat misinformation through a robust social media presence as “The Science Maven” and helps other scientists and clinicians to do the same. "If we're not there to fill in that void, other people will fill it for us and the narrative may not be consistent with the truth or facts." This is a great opportunity to learn about the art and science of communications that can reach clinicians and patients alike.Mentioned in this episode:Cohen Center for Recovery from Complex Chronic IllnessThe Science Maven If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former Chinook board member, Rouzbeh Haghighat, has been indicted for insider trading related to Novartis' $3.2 billion acquisition of the company. Despite this scandal, pharma R&D spending increased in 2024, climbing 1.5% across the global pharmaceutical sector. The acquisition of SiteOne by Lilly follows Vertex into the non-opioid pain space, providing diversification for Lilly, which has been focusing on obesity and diabetes treatments. Meanwhile, AbbVie's Allergan cuts over 200 staff after a botched marketing campaign, and Inflarx axes a rare skin disease study due to disappointing late-stage data.AGC Biologics will be at Bio International in Boston to showcase their global capabilities in drug production. Vaccine overhaul, rocket grounding, and drug price transparency are also highlighted in the latest news. Biogen's strategy for Zurzuvae shifts as obstetricians/gynecologists rise to the front lines. Drug price transparency in the US is discussed as being easier said than done. Additionally, Rocket's gene therapy for Danon disease is on hold after a patient death, and four biotechs are facing uncertainty in the COVID-19 vaccine landscape.Global pharmaceutical companies are increasing their research and development spending despite political and economic challenges. Biogen is shifting its strategy for the drug Zurzuvae as obstetricians and gynecologists become more involved. Drug price transparency in the US is still a challenge, despite efforts to increase transparency. Trilink has introduced a new poly(A) tail modification to enhance protein expression.In other news, a former Chinook board member has been indicted for insider trading, Trump has appointed Dr. Oz to lead drug pricing negotiations, and Lilly is following Vertex into non-opioid pain treatment with a SiteOne acquisition. Sanofi has purchased Vigil for $470 million to reignite an Alzheimer's target.

In this engaging conversation, Lucas Aoun interviews biohacking pioneer Dave Asprey, exploring the core drivers of accelerated aging, the impact of societal stressors, and the dangers of microplastics and mold. Asprey shares insights on detoxification strategies, essential foods for optimal health, and the importance of continuous glucose monitoring. The discussion also delves into leaky gut and its connection to autoimmune diseases, providing listeners with actionable takeaways for improving their health and longevity. In this conversation, Dave and Lucas delve into various aspects of health, focusing on gut health, the role of pharmaceuticals, liver health, and the impact of AI on healthcare. They explore the importance of understanding parasites, the benefits of certain medications, and the significance of liver detoxification. The discussion also touches on the concept of mitochondrial consciousness and personal development, emphasizing how fear and legacy influence human behavior and health. Dave shares insights from his experiences and research, advocating for a holistic approach to health and wellness.Relevant Links:Dave Asprey's New Book:https://daveasprey.com/heavily-meditated/Dave Asprey Biohacking Conference:https://biohackingconference.com/2025The Business Of Biohacking Summit:https://daveasprey.com/business-of-biohacking/Follow Dave Asprey On Instagram:https://www.instagram.com/dave.asprey/?hl=enCheck Out My Website For Coaching, Recommended Products and Much More:https://www.boostyourbiology.com/ Disclaimer:The information provided in this podcast episode is for entertainment purposes and is NOT MEDICAL ADVICE. If you have any questions about your health, contact a medical professional. This content is strictly the opinions of Lucas Aoun and is for informational and entertainment purposes only. It is not intended to provide medical advice or to take the place of medical advice or treatment from a personal physician. All viewers of this content are advised to consult with their doctors or qualified health professionals regarding specific health questions. Neither Lucas Aoun nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this content. All consumers of this content especially taking prescription or over-the-counter medications should consult their physician before beginning any nutritional, supplement or lifestyle program.Chapters00:00 Introduction to Biohacking and Aging02:39 The Impact of Societal Stressors on Aging04:50 Microplastics and Detoxification Strategies07:36 Understanding Mold and Its Health Implications12:42 The Dangers of Mold Toxins18:32 Essential Foods for Optimal Health20:06 Insights from Continuous Glucose Monitoring26:17 Leaky Gut and Autoimmune Diseases29:01 Understanding Parasites and Gut Health32:35 The Role of Pharmaceuticals in Gut Healing36:30 Exploring Liver Health and Detoxification39:23 AI's Impact on Healthcare and Biohacking41:44 Mitochondrial Consciousness and Personal Development47:27 Legacy, Fear, and the Human Experience Hosted on Acast. See acast.com/privacy for more information.

EPISODE DESCRIPTIONLisa Shufro is the storyteller's storyteller. A musician turned innovation strategist, TEDMed curator, and unapologetic truth-teller, Lisa doesn't just craft narratives—she engineers constellations out of chaos. We go way back to the early TEDMed days, where she taught doctors, scientists, and technocrats how not to bore an audience to death. In this episode, we talk about how storytelling in healthcare has been weaponized, misunderstood, misused, and still holds the power to change lives—if done right. Lisa challenges the idea that storytelling should be persuasive and instead argues it should be connective. We get into AI, the myth of objectivity, musical scars, Richard Simmons, the Vegas healthcare experiment, and the real reason your startup pitch is still trash. If you've ever been told to “just tell your story,” this episode is the permission slip to do it your way. With a bow, not a violin.RELATED LINKSLisa Shufro's WebsiteLinkedInSuper Curious ArchiveEight Principles for Storytelling in InnovationStoryCorps InterviewCoursera Instructor ProfileWhatMatters ProjectFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

⚠️ Content Warning: This episode contains a discussion around suicidal thoughts. Please take care while listening and seek support if you need it.Living with Complex Regional Pain Syndrome (CRPS) isn't just painful—it's punishing. It hijacks your body, messes with your mind, and turns everyday tasks into uphill battles. In this episode, Lyndsay Soprano sits down with Jeannette Tashjian for a brutally honest conversation about what it really means to live with relentless, unpredictable pain.They talk about the parts most people don't see: the mental spiral, the isolation, the weight of explaining yourself over and over, and the moments when giving up feels like the only option. But they also talk about what keeps them going—connection, infrared sauna therapy, self-advocacy, and the power of simply being heard.This episode doesn't sugarcoat anything. From navigating life with a disability to confronting the stigma around suicidal thoughts, Jeannette and Lyndsay lay it all out. They speak from the gut—about grief, about resilience, and about finding pieces of joy in a body that feels like it's working against you.If you've ever felt like no one understands what you're going through—or if you love someone who lives with chronic pain—this conversation will hit home.Tune in for the truth behind CRPS, and the reminder that you're not alone in this fight.Find Jeanette Tashjian Online Here:Website: www.burbankinfraredsauna.comInstagram: @burbankinfraredsaunaPast Guest Episode 6: The Pain Game Podcast Episode 6Find The Pain Game Podcast Online Here:Website: thepaingamepodcast.comInstagram: @thepaingamepodcastFacebook: The Pain Game PodcastLinkedIn: Lyndsay SopranoYouTube: The Pain Game PodcastIF YOU'RE IN CRISIS:USA – Call or text 988 (24/7)Canada – Call: 1-833-456-4566 (24/7) | Text: 45645 (4 PM–12 AM EST)Episode Highlights:(00:00) Introduction to Chronic Pain and Trauma(03:12) Understanding Complex Regional Pain Syndrome (CRPS)(06:01) Personal Stories of Pain and Trauma(08:52) The Role of Infrared Sauna in Pain Management(12:11) Navigating Life with CRPS(14:58) Acceptance and Coping Mechanisms(18:07) The Importance of Community and Support(23:42) Finding Freedom in Acceptance(30:43) Navigating the Pain Journey(31:12) Addressing Suicidal Thoughts(43:45) The Importance of Hope and Support

More than a third of patients released from the hospital never fill their discharge prescriptions, but “meds-to-beds” programs can help improve that statistic. That is the approach Renown Health in Reno, Nev., took with the help of its 340B savings. Renown Vice President of Pharmacy Services Adam Porath joins us to describe how this meds-to-beds program improves patient care.Hospital readmissions down, patient convenience upRenown Health's 340B-funded program offers medication to patients who are being discharged from the hospital, either through bedside delivery, pneumatic tube, or a unique discharge lounge. The effort began as a pilot for Medicaid patients in 2016, and it demonstrated patients in the program were 25% less likely to be readmitted to the hospital once discharged. These health improvements plus the added convenience of medication access for patients convinced the system to expand the program.340B pricing to patients who cannot payPorath says Renown Health refers patients who cannot afford discharge medications to its social services team, which can authorize providing the drugs to those patients at the 340B-discounted rate. The team also will work with patients to see if they qualify for coverage such as Medicaid or other programs to reduce their out-of-pocket costs. Porath said Renown's meds-to-beds program provides drugs free of charge to about 30 patients per month.The keys to successRenown Health's meds-to-beds program has been a success, with more than 80% of eligible patients participating as of the end of 2024. The hospital expanded the services to all patients and started operating it 24/7 in April 2024. Porath said the keys to success include regular reporting to stakeholders and innovations to handle a large volume of patients discharging at once. Such changes allow all parties to stay in the loop with the development of the program and to celebrate successes as they occur.ResourcesRead Our Analysis of the First Federal Court Decision on RebatesSecond Federal Judge Allows 340B Health, Member Hospitals To Intervene in Rebate Lawsuit

This episode focuses on writing for medical devices. Playing Sherlock Holmes, conducting usability studies, following regulations, working closely with the manufacturers and much more are all in a day's work when writing for devices. Listen to Trilogy's medical writing managers, Heidi Chapman and Laura Collada, and Senior Partner, Julia Forjanic Klapproth, discuss the similarities and differences between writing for devices and writing for drugs. Listen up!   

Mariano Mattei is the Vice President of Cybersecurity and AI at Azzur Solutions, bringing over 30 years of expertise in cybersecurity, AI innovation, and software engineering. A Certified Chief Information Security Officer (CCISO), Mariano has led AI-driven transformations across Biotechnology, Pharmaceuticals, and Medical Device sectors, integrating AI into clinical trials, manufacturing automation, quality systems, and regulatory compliance frameworks (FDA 21 CFR Part 11, GAMP 5, GDPR, HIPAA). His work spans predictive analytics for risk management, AI-powered process optimization, anomaly detection in manufacturing, and regulatory AI governance. He recently graduated from Temple University's Master's Program in Cyber Defense and Information Assurance, and he's the author of "Data-Driven Cybersecurity – Proven Metrics for Reducing Cyber Risk"Listen NOW to discover, "The Secret to Taking A Secure Risk"

Let's start with, What the Heck is a Hack? A hack is a small change or a shortcut designed to improve your life. Today's guest, Zora Benhamou, is the Queen of Midlife Health Hacks. She's also someone who, despite living a very active life, ended up with osteoarthritis.  She tried to avoid surgery for as long as possible. How was she able to do that? She used a few health hacks to get as much "life" out of her hips as possible. She tried PRP, physical therapy, and an anti-inflammatory diet. On the podcast, she discusses a few more hacks that you've got to hear about! Let's also talk about scars. Zora ended up with two hip replacements, and she tried a few different hacks to lessen her scarring. She used a copper peptide cream on one scar and a different product on the other. The copper peptide scar improved so much that she started using it on both wounds, and she's thrilled with the results! I just bought this copper peptide cream, Zora suggested using the link below (20% off!) https://www.vitaliskincare.com/discount/cancerwarrior?ref=cbkmpsij ____ Water Filtration: Boroux I've been looking for a water filter for two years. Okay, maybe I'm a little picky...but my research paid off. I've chosen the Boroux Filter system and am really happy with it. Are you curious about my criteria? Here's what I was looking for in a filter: Removal of heavy metals. The Boroux removes 99.36% of heavy metals. Pharmaceuticals are removed. Because people don't dispose of drugs properly, the drugs get into our water system. The Boroux removes 99.5% of pharmaceutical contaminants. Glyphosate removal (glyphosate is the active ingredient in Roundup and is a known carcinogen). A year ago, I was tested for glyphosate and was in the 95th percentile. I was shocked! Since I was already eating mainly organic, my doctor suggested getting a water filter. I had a challenging time finding one that would filter this chemical, and this was one of my main drivers for purchasing this filter. Boroux has a special offer for my community. Click the link below to research and purchase. https://boroux.sjv.io/7aM1a3 ____ Air Dr. I've been using the Air Doctor air purifier for almost a year and absolutely love it! I first heard about it from Dr. Mark Hyman, and even though it was a bit of a splurge compared to what I usually spend, I'm so glad I invested. Every time I change the filter and see all the gunk it collects, I smile, knowing it's doing a great job keeping my air clean! And I'm so happy that all that gunk isn't going into my body ;) Click here to purchase: https://airdoctorpro.com/?oid=17&affid=6165 ____ Connect with Zora Benhamou Website: https://hackmyage.com/ Instagram: https://www.instagram.com/hackmyage/ Facebook: https://www.facebook.com/HackMyAge LinkedIn: https://www.linkedin.com/in/zora-benhamou-37167017/ X: https://x.com/hackmyage ______ Connect with Deborah Deborah on Instagram: https://www.instagram.com/whydidigetcancer/ Deborah on Facebook: https://www.facebook.com/DebsHealthCoachKitchen Deborah on Twitter: https://twitter.com/ydidigetcancer Deborah on Pinterest: https://in.pinterest.com/whydidigetcancer/ Join Deb's weekly newsletter!  -https://whydidigetcancer.us14.list-manage.com/subscribe?u=1c37affeccf004c8957941069&id=a8572db3c2

In this eye-opening episode of the Healthy & Awake Podcast, holistic veterinarian Dr. Judy Morgan reveals the hidden dangers of toxic pet food, overprescribed pet vaccines, and harmful pharmaceuticals like trazodone for dogs. With over 40 years of experience, she shares how natural pet care and raw food for dogs can dramatically improve your pet's health and longevity. We explore powerful alternatives like CBD for pets, mushroom therapy, food-based healing, and why many chronic illnesses and dog cancer cases may be preventable. This is a must-watch for anyone who loves their animals and wants the truth about the veterinary industry, veterinary corruption, and how to make smarter, safer choices. Learn how the microbiome, environmental toxins, and holistic medicine are changing the game for pets everywhere.Dr. Judy Morgan's Website https://drjudymorgan.comNaturally Healthy Pets (her company) https://naturallyhealthypets.comDr. Judy U (her online course platform) https://drjudyu.com___________________________

What happens when you blend the soul of Mr. Rogers, the boldness of RuPaul, and just a pinch of Carrie Bradshaw? You get Sally Wolf.She's a Harvard and Stanford powerhouse who ditched corporate media to help people actually flourish at work and in life—because cancer kicked her ass and she kicked it back, with a pole dance routine on Netflix for good measure.In this episode, we unpack what it means to live (really live) with metastatic breast cancer. We talk about the toxic PR machine behind "pink ribbon" cancer, how the healthcare system gaslights survivors when treatment ends, and why spreadsheets and dance classes saved her sanity. Sally doesn't just survive. She rewrites the script, calls out the BS, and shows up in full color.If you've ever asked “Why me?”—or refused to—this one's for you.RELATED LINKS:Sally Wolf's WebsiteLinkedInInstagramCosmopolitan Essay: "What It's Like to Have the 'Good' Cancer"Oprah Daily Article: "Five Things I Wish Everyone Understood About My Metastatic Breast Cancer Diagnosis"Allure Photo ShootThe Story of Our Trauma PodcastFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

- Interview with Diane Keyser on Healing and Natural Beauty (0:11) - Special Report on MSG Toxicity (0:54) - Engineer Recruitment and Project Delays (2:20) - Spiritual Reflections and Personal Anecdotes (5:36) - Joe Biden's Prostate Cancer Diagnosis and Second Amendment Victory (9:17) - Challenges in Health and Nutrition (10:04) - Exploring Different Belief Systems (20:07) - Experiments and Demonstrations (24:15) - The War on Cognition and MSG Toxicity (57:19) - Hidden Sources of MSG in Food (1:09:20) - Fast Food Chains and MSG (1:18:57) - Fast Food and MSG: A Comprehensive Overview (1:24:49) - Health Consequences of MSG (1:27:10) - Comparing Fast Food to Packaged Grocery Store Food (1:28:48) - The History and Impact of MSG (1:31:55) - Cultural and Historical Context of MSG (1:34:21) - Personal Experiences and Advocacy (1:37:57) - The Role of Peptides in Health and Wellness (2:10:21) - The Science Behind Peptides (2:12:25) - Practical Applications and Personal Testimonies (2:13:39) - The Future of Peptides and Health Advocacy (2:13:53) - Body as a Molecular Factory (2:14:47) - Peptides and Their Miraculous Effects (2:43:11) - C Max and Its Cognitive Benefits (2:44:50) - Oxytocin and Its Role in Hormone Regulation (2:48:01) - Peptides vs. Pharmaceuticals (2:49:23) - BPC 157 and Its Benefits for Injuries (2:51:10) - Environmental Toxins and Their Impact on Health (2:56:18) - Personalized Peptide Therapy (3:05:05) - Injectable Peptides and Their Administration (3:08:05) - Conclusion and Call to Action (3:20:51) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Kinsella on Liberty Podcast: Episode 465. GROK SHOWNOTES: [0:00–9:16] In this engaging episode of the Kinsella on Liberty podcast, Stephan Kinsella and Sheldon Richman tackle the contentious issue of pharmaceutical price controls under Trump's executive order, questioning their equivalence to traditional price controls that distort markets. Kinsella, drawing on his extensive critique of intellectual property (Patents and Pharmaceuticals, 2023; Patents, Pharma, Government: The Unholy Alliance, 2024), argues that patents create artificial monopolies, so price controls countering these are not standard interventions but responses to government-granted privileges. Richman highlights FDA-imposed costs, which patents partially offset, though Kinsella counters that these costs are overstated, citing lower drug prices abroad (Drug Reimportation, 2009). They endorse reimportation as a market-based solution, referencing Connor O'Keefe's analysis (Mises: How Trump Can Lower Drug Prices Without Price Controls, 2025), but criticize Trump's coercive tactics as resembling a protection racket (Trump's Worst Idea: Pharmaceuticals, 2025) (0:02–6:00). The discussion also critiques antitrust laws and secondary regulations, with Richman warning against Kevin Carson's approach of layering controls atop privileges (Kevin Carson on Confiscating Property from the Rich, 2016) (6:00–9:16). [9:16–1:13:35] The conversation shifts to a robust defense of the corporate form, addressing left-libertarian criticisms of limited liability and shareholder responsibility. Kinsella, aligning with Robert Hessen's contractual view and his own writings (Corporate Personhood, Limited Liability, and Double Taxation, 2011; Left-Libertarians, Corporations, Expropriating Stakeholders, 2008), argues that limited liability is not a privilege but a logical outcome of action-based responsibility, where shareholders are not liable unless causally responsible for torts (Van Dun on Freedom versus Property and Hostile Encirclement, 2009). Richman decries the pejorative use of “corporate” by figures like Roderick Long, rejecting claims that corporations inherently rely on state favoritism (Comment on Left-Libertarianism on Roderick Long's Sub-Ex Dep Post, 2009) (9:16–36:01). They explore thick libertarianism, agreeing that individualism connects to broader values but remains distinct, and critique Walter Block's evictionism on abortion, with Kinsella arguing fetuses are not trespassers due to maternal actions (Together Strong Debate with Walter Block, 2022) (36:01–1:13:35). A lighthearted discussion on pipe tobacco reflects their commitment to personal liberty, underscoring their broader libertarian principles (Wombatrons: Why I Am a Left-Libertarian, 2009). https://youtu.be/5YaTsoDH9Eg Grok detailed shownotes: Detailed Segment Summary for Show Notes Segment 1: Price Controls, Patents, and Reimportation (0:02–9:16) Description and Summary: Kinsella andMemphis-based Robert Hessen and Sheldon Richman discuss Trump's pharmaceutical price control executive order, questioning its implications. Kinsella, per his writings (Patents and Pharmaceuticals, 2023; Patents, Pharma, Government: The Unholy Alliance, 2024), argues that patents create monopoly prices, so price controls countering these aren't standard market distortions, as patents themselves are government-granted (IP vs. Antitrust, 2005). Richman notes FDA costs inflate drug prices, but Kinsella cites lower prices abroad to argue these costs are overstated (Drug Reimportation, 2009) (0:02–2:28). They advocate reimportation, citing Connor O'Keefe's market-based approach (Mises: How Trump Can Lower Drug Prices Without Price Controls, 2025), and criticize Trump's coercive tactics as a protection racket (Trump's Worst Idea: Pharmaceuticals, 2025) (2:28–6:00). The segment critiques antitrust laws and secondary regulations, with Richman comparing them to Kevin Carson's flawed approach (Kevin Carson on Confisca...

Why are childhood cancers on the rise? Is there any news more heartbreaking than hearing about another child diagnosed with cancer? Reflecting on my own childhood, I remember a friend from seventh grade who was diagnosed with cancer. Surprisingly, that was the only case I encountered from kindergarten all the way through my college graduation. What has changed in our world that has exponentially increased the risk of cancer for our children and young people? I spoke with Functional Nutritional Therapy Practitioner Season Johnson. She is also a cancer mom who helped her son battle cancer for nearly four years. Her son is thriving now, and she shares tips and guidance on how to help protect your kids from this disease. She offered some tips I hadn't even considered, and now I'm implementing them! Please listen to the episode and share this information with all your friends who are parents or grandparents! P.S. I've only "met" Season online, but last month, while I was in San Diego, I saw her walking down the street with a cup of coffee. I ran over to say hi—what a small world! ____ Water Filtration: Boroux  I've been looking for a water filter for two years. Okay, maybe I'm a little picky...but my research paid off. I've chosen the Boroux Filter system and am really happy with it. Are you curious about my criteria? Here's what I was looking for in a filter: Removal of heavy metals. The Boroux removes 99.36% of heavy metals. Pharmaceuticals are removed. Because people don't dispose of drugs properly, the drugs get into our water system. The Boroux removes 99.5% of pharmaceutical contaminants. Glyphosate removal (glyphosate is the active ingredient in Roundup and is a known carcinogen). A year ago, I was tested for glyphosate and was in the 95th percentile. I was shocked! Since I was already eating mainly organic, my doctor suggested getting a water filter. I had a challenging time finding one that would filter this chemical, and this was one of my main drivers for purchasing this filter. Boroux has a special offer for my community. Click the link below to research and purchase. https://boroux.sjv.io/7aM1a3 ____ Air Dr. I've been using the Air Doctor air purifier for almost a year and absolutely love it! I first heard about it from Dr. Mark Hyman, and even though it was a bit of a splurge compared to what I usually spend, I'm so glad I invested. Every time I change the filter and see all the gunk it collects, I smile, knowing it's doing a great job keeping my air clean! And I'm so happy that all that gunk isn't going into my body ;) Click here to purchase: https://airdoctorpro.com/?oid=17&affid=6165 ______ Connect with Season Johnson Website: https://www.seasonjohnson.com/ Instagram: https://www.instagram.com/seasonjohnson/ Facebook: https://www.facebook.com/seasonmjohnson/ LinkedIn: https://www.linkedin.com/in/season-johnson/ ______ Connect with Deborah Deborah on Instagram: https://www.instagram.com/whydidigetcancer/ Deborah on Facebook: https://www.facebook.com/DebsHealthCoachKitchen Deborah on Twitter: https://twitter.com/ydidigetcancer Deborah on Pinterest: https://in.pinterest.com/whydidigetcancer/ Join Deb's weekly newsletter!  -https://whydidigetcancer.us14.list-manage.com/subscribe?u=1c37affeccf004c8957941069&id=a8572db3c2

On this episode of “Raise the Line” we welcome Dr. Sheldon Fields, a trailblazer in the nursing field and the president of the National Black Nurses Association. In a candid conversation, Dr. Fields shares his inspiring journey from the bedside to becoming a prominent figure in nursing, HIV/AIDS prevention and academia and also shares the challenges he faced as a Black man in a predominantly white and female field. "I fell in love with a profession that has not always loved me back," he tells host Kelsey Lafayette. Dr. Fields brings over thirty years of experience as an educator, researcher, clinician, administrator, consultant, health policy specialist, and entrepreneur to his current role at NBNA, and as the inaugural associate dean for equity and inclusion at the College of Nursing at Penn State University, where he also serves as a research professor. Listeners will find Dr. Fields' insights on navigating a career in healthcare particularly valuable, as he stresses the importance of resilience, continuing education, and mentorship. It's a compelling listen for anyone interested in the intersection of health, policy, and social justice.Mentioned in this episode:National Black Nurses Association If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

President Trump's executive order targeting prescription drug costs does not implement traditional price controls. Instead, it seeks to lower prices through mechanisms such as international reference pricing and increased market competition. The President has actively defended the executive order in public statements and media appearances, emphasizing its goal of making medications more affordable for Americans without resorting to heavy-handed government regulation. Jake Tapper has released a new book offering an in-depth look at the Biden presidency claiming the administration covered up the president's cognitive decline. Meanwhile, he claims, as a member of the media, he didn't play a role in that cover up.   Freedom Marketplace: https://freedommarketplace.net The Stack: https://www.toddhuffshow.com/stack-of-stuff Email: todd@toddhuffshow.comPhone: 317.210.2830Follow us on…Instagram: @toddhuffshowFacebook: The Todd Huff ShowTwitter: @toddhuffshowLinkedIn: The Todd Huff ShowTikTok: @toddhuffshowSupport Our Partners:https://www.toddhuffshow.com/partners Links:https://www.mypillow.com/todd Promo Code: TODDhttps://mystore.com/toddhttps://soltea.com - Promo Code TODD for $29.95 off your first orderEaston University - https://www.eastonuniversity.comkenaifish.com - Promo Code TODD to save 15%

President Trump's executive order targeting prescription drug costs does not implement traditional price controls. Instead, it seeks to lower prices through mechanisms such as international reference pricing and increased market competition. The President has actively defended the executive order in public statements and media appearances, emphasizing its goal of making medications more affordable for Americans without resorting to heavy-handed government regulation. Jake Tapper has released a new book offering an in-depth look at the Biden presidency claiming the administration covered up the president's cognitive decline. Meanwhile, he claims, as a member of the media, he didn't play a role in that cover up.   Freedom Marketplace: https://freedommarketplace.net The Stack: https://www.toddhuffshow.com/stack-of-stuff Email: todd@toddhuffshow.comPhone: 317.210.2830Follow us on…Instagram: @toddhuffshowFacebook: The Todd Huff ShowTwitter: @toddhuffshowLinkedIn: The Todd Huff ShowTikTok: @toddhuffshowSupport Our Partners:https://www.toddhuffshow.com/partners Links:https://www.mypillow.com/todd Promo Code: TODDhttps://mystore.com/toddhttps://soltea.com - Promo Code TODD for $29.95 off your first orderEaston University - https://www.eastonuniversity.comkenaifish.com - Promo Code TODD to save 15%

Americans have been shouldering the cost of medicines, while the rest of the world has received a discount, according to the White House. And now, the Trump administration says it's putting an end to the practice. The president's new executive order is expected to reduce the costs of medications in the United States while causing the costs to rise in other countries.In other news, the Trump administration is now negotiating a trade deal with the Chinese regime. After meetings over the weekend, it was announced that both countries would temporarily lower their tariffs, and that this will last around 90 days while talks continue.Views expressed in this episode are opinions of the host and guests and do not necessarily reflect the views of The Epoch Times.

Thanks for listening to The Morning Five! Thanks for listening, rating/subscribing The Morning Five on your favorite podcast platform. Learn more about the work of CCPL at www.ccpubliclife.org. Michael's new book, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Spirit of Our Politics: Spiritual Formation and the Renovation of Public Life⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, is now available! You can order on Amazon, Bookshop.org, Barnes & Noble, or at your favorite local bookstore. Join the conversation and follow us at: Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@michaelwear⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, @ccpubliclife Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@MichaelRWear⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, @ccpubliclife And check out ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@tsfnetwork⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: King Sis #politics #faith #prayer #Ephesians4 #PopeLeoXIV #healthcare #China #US #drugprices #executiveorder #trade #economics #tariffs Learn more about your ad choices. Visit megaphone.fm/adchoices

Big potential changes to how 340B operates plus heightened interest in both new protections and new restrictions for covered entities means there is much to keep track of in the 340B world. 340B Health CEO Maureen Testoni joins us to make sense of recent developments in the nation's courts and beyond.Rebates Get Their Day in Court340B Health, two member hospitals, and the government met drug companies in court in late April to challenge drugmaker attempts to replace 340B discounts with rebates. Testoni says the judge cited potentially devastating consequences to hospitals if rebates proceeded but also had probing questions for the government on how it is working to address drugmaker compliance concerns. The Dept. of Health and Human Services is set to release guidance by early June on the rebate issue, and the court's decision could come out soon.The White House Proposes 340B Big Oversight Shift A leaked copy of the Trump administration's latest budget proposal includes a plan to move the Office of Pharmacy Affairs (OPA) from the Health Resources & Services Administration to the Centers for Medicare & Medicaid Services. Testoni says the oversight shift is concerning because of a stark difference between the purpose of 340B and the operations of Medicare and Medicaid. CMS also imposed years of Medicare payment cuts to 340B hospitals that the U.S. Supreme Court eventually overturned.340B Protections, Mandates Take Center StageStates continue enacting laws to protect hospital access to 340B pricing, but they also are moving forward with reporting mandates and proposals to define how hospitals should use their savings. Testoni said reporting and use-of-savings mandates lead to misdirected views on the purpose of 340B, which goes far beyond direct patient care and cost assistance. On Capitol Hill, a report from a long-running investigation of 340B recently came out, contributing to the debate over possible new restrictions.ResourcesFederal Government Signals Upcoming Guidance on 340B Rebate Models Amid Legal ChallengesBrief Your Leaders on White House Plans for Major 340B ChangesNebraska Is 12th State To Enact Contract Pharmacy ProtectionsIndiana Becomes Fifth State To Mandate 340B Reports From HospitalsKey Senator Concludes 340B Investigation, Calls for Major ReformsNew 340B Health Research340B Impact Profiles

Oh Lord, help me to relax and push the pause button. Today's guest, Dr. Natalie Greenberg from The Center for New Medicine, explained how important it is for my health to hit the pause button. She also mentioned that when life gets overwhelming, It's crucial to pause and take a deep breath before reacting to any situation. Her words spoke to me. I tend to be an "over-responder." I might get irritated with someone before I have all the information about a situation. I might wake up upset because of a restless night, and my negative thoughts kick in, telling me how tough the day will be. How could my life be different if, instead of following my default of reacting, I took a minute, slowed down my breathing, pushed the pause button, gathered my thoughts, and then responded INSTEAD of reacting? Nervous System: This would help my body stay in a parasympathetic state (the rest and digest state), so my body wouldn't produce as many stress hormones. This means I'd have lower levels of inflammation and, honestly, better relationships! Immune System: Staying calm supports the immune system and allows your body to produce more "happy hormones," such as serotonin and melatonin, which means you fall asleep faster. The Joy Factor: thinking the best about people means I look for joy everywhere I go. When I see someone wearing a cute outfit or making me a fabulous matcha latte, I PRAISE THEM! The Bible says, to the best of my abilities, be at peace with people at all times. Pro tip: The scripture above says that, to the best of my abilities, sometimes it's impossible to be at peace with some people, and you know what? That's okay, too. The older I get, the more I realize my gift to people is letting them be who they are. ____ Water Filtration: Boroux  I've been looking for a water filter for two years. Okay, maybe I'm a little picky...but my research paid off. I've chosen the Boroux Filter system and am really happy with it. Are you curious about my criteria? Here's what I was looking for in a filter: Removal of heavy metals. The Boroux removes 99.36% of heavy metals. Pharmaceuticals are removed. Because people don't dispose of drugs properly, the drugs get into our water system. The Boroux removes 99.5% of pharmaceutical contaminants. Glyphosate removal (glyphosate is the active ingredient in Roundup and is a known carcinogen). A year ago, I was tested for glyphosate and was in the 95th percentile. I was shocked! Since I was already eating mainly organic, my doctor suggested getting a water filter. I had a challenging time finding one that would filter this chemical, and this was one of my main drivers for purchasing this filter. Boroux has a special offer for my community. Click the link below to research and purchase. https://boroux.sjv.io/7aM1a3 ____ Just Add Buoy Companies contact me every week, asking me to try their products. Honestly, I get food and supplement samples almost weekly! Last week, a San Diego company called Just Add Buoy emailed me to ask if I wanted to try their electrolyte formula. I said yes because I've been looking for an electrolyte formula (without tons of sugar, both fake and real and no dyes) for years. They sent me some samples, and I must tell you how much I love them. I'm trying the Hydration Drops, and they have 87 trace minerals, Ionic ocean electrolytes, and antioxidants. And, also important to me, NO SUGAR (FAKE OR REAL), NO ADDITIVES OR DYES. And it's non-GMO. I like that it's flavorless, and I can add it to a smoothie or even my morning coffee without noticing any flavor change. Use the link below to get 20% off of your order. https://www.justaddbuoy.com/DEBORAH10729 ____ About  Dr. Natalie Greenberg Dr. Natalie Greenberg, a licensed naturopathic doctor, is dedicated to empowering individuals to achieve optimal health. Her journey began after a battle with Lyme disease and mold exposure, leading her to explore the world of natural healing. After receiving her undergraduate degree from Columbia University, Dr. Greenberg pursued naturopathic medicine at Bastyr University. There, she gained expertise in various areas, including pediatrics, gynecology, cardiology, autoimmune diseases, and mental health. Her training also encompassed holistic therapies like nutrition, IV therapy, homeopathy, and craniosacral therapy. During her final year of school, Dr. Greenberg worked closely with Dr. Leigh Erin Connealy, a renowned expert in cancer care. Together, they focused on providing adjunctive care for cancer patients, helping them navigate their healing journey. Driven by her personal experience with Lyme disease and mold, Dr. Greenberg is passionate about supporting patients with these conditions. She offers functional medicine approaches to address the root causes of their symptoms and promote overall well-being. Additionally, she is committed to supporting individuals with early-stage cancer, providing adjunctive care alongside conventional treatments. Dr. Greenberg's holistic approach to healthcare aligns with the mission of preventive medicine and human optimization. She believes in empowering individuals to take control of their health and live their best lives. Connect With Dr. Natalie Greenberg  Dr. Natalie Greenberg can be found on Instagram at @dr.nataliegreenberg The Center For New Medicine can be found on Instagram at @centerfornewmedicine Learn more about Dr. Natalie Greenberg at the Center for New Medicine website: https://cfnmedicine.com/ ____ Connect with Deborah Deborah on Instagram: https://www.instagram.com/whydidigetcancer/ Deborah on Facebook: https://www.facebook.com/DebsHealthCoachKitchen Deborah on Twitter: https://twitter.com/ydidigetcancer Deborah on Pinterest: https://in.pinterest.com/whydidigetcancer/ Join Deb's weekly newsletter Here!

Plus: Germany's Friedrich Merz wins chancellorship on second vote, starting his term in a weakened position. DoorDash reports a first-quarter profit, and plans to acquire Deliveroo and SevenRooms. And the EU lays out plans to cut Russian energy imports by 2027. Charlotte Gartenberg hosts. Sign up for the WSJ's free What's News newsletter.  Learn more about your ad choices. Visit megaphone.fm/adchoices

- Green Tea and Cognitive Benefits (0:10) - Critique of Pharmaceuticals and Big Pharma (2:39) - Green Tea and Brain Health (4:31) - Speed Cubing and Cognitive Training (10:47) - Green Tea and Cancer Prevention (15:59) - Green Tea and Heavy Metal Detoxification (24:45) - L-Theanine and Anxiety Relief (30:04) - Catechins and Polyphenols in Green Tea (36:21) - Green Tea Extracts and Supplements (39:14) - Green Tea and Cancer Therapy (50:57) - Colloidal Silver and Its Benefits (1:11:38) - Silver Nanoparticles and Cancer Research (1:23:02) - Historical and Metaphysical Significance of Metals (1:26:08) - Economic and Political Implications of Metals (1:27:53) - Challenges and Opportunities in Health and Science (1:30:08) - Personal Reflections and Future Plans (1:37:17) - Final Thoughts and Gratitude (1:41:15) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com